These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33534766)

  • 1. Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018.
    Walker AT; Gershman MD; Rao SR; LaRocque RC; Ryan ET;
    Am J Trop Med Hyg; 2021 Jan; 104(3):1079-1084. PubMed ID: 33534766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.
    Gershman MD; Sotir MJ
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):780. PubMed ID: 28749924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.
    Gershman MD; Angelo KM; Ritchey J; Greenberg DP; Muhammad RD; Brunette G; Cetron MS; Sotir MJ
    MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):457-459. PubMed ID: 28472025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA.
    Rojas A; Hachey W; Kaur G; Korejwo J; Muhammad R
    J Travel Med; 2023 Nov; 30(7):. PubMed ID: 37000007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
    Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers.
    Lown BA; Chen LH; Han PV; Jentes ES; Wilson ME; Benoit CM; Avery KA; Ooi W; Hamer DH; Barnett ED;
    J Travel Med; 2014; 21(4):266-71. PubMed ID: 24734961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?
    Wyplosz B; Leroy JP; Derradji O; Consigny PH
    J Travel Med; 2015; 22(2):140-1. PubMed ID: 25384441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to yellow fever travel vaccination centres in England, Wales, and Northern Ireland: A geographical study.
    Petersen J; Simons H; Patel D
    Travel Med Infect Dis; 2017; 18():24-29. PubMed ID: 28698027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yellow fever vaccine: an effective vaccine for travelers.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel.
    Hagmann SHF; Rao SR; LaRocque RC; Erskine S; Jentes ES; Walker AT; Barnett ED; Chen LH; Hamer DH; Ryan ET;
    Obstet Gynecol; 2017 Dec; 130(6):1357-1365. PubMed ID: 29112671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.
    Nasveld PE; Marjason J; Bennett S; Aaskov J; Elliott S; McCarthy K; Kanesa-Thasan N; Feroldi E; Reid M
    Hum Vaccin; 2010 Nov; 6(11):906-14. PubMed ID: 20864814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Piras-Douce F; Raynal F; Raquin A; Girerd-Chambaz Y; Gautheron S; Sanchez MEN; Vangelisti M; Mantel N
    Vaccine; 2021 Mar; 39(13):1846-1856. PubMed ID: 33685778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium.
    Dolan SB; Jentes ES; Sotir MJ; Han P; Blanton JD; Rao SR; LaRocque RC; Ryan ET; ; Abraham GM; Alvarez S; Ansdell V; Yates JA; Atkins EH; Cahill J; Birich HK; Vitek D; Connor BA; Dismukes R; Kozarsky P; Dosunmu R; Goad JA; Hagmann S; Hale D; Hynes NA; Jacquerioz F; McLellan S; Knouse M; Lee J; LaRocque RC; Ryan ET; Oladele A; Demeke H; Pasinski R; Wheeler AE; Rao SR; Rosen J; Schwartz BS; Stauffer W; Walker P; Vinetz J
    Vector Borne Zoonotic Dis; 2014 Feb; 14(2):160-7. PubMed ID: 24359420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial with unlicensed yellow fever vaccine in Japan.
    Ujiie M; Terada M; Kobayakawa M; Ohmagari N
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 30657930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group].
    Martinho C; Lopes D; Bastos L; Esteves H
    Acta Med Port; 2018 Dec; 31(12):724-729. PubMed ID: 30684369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 20. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    Staples JE; Bocchini JA; Rubin L; Fischer M;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.